AI주식인사이트AI Stock Insight
C

플라즈맵

405000KOSDAQ

43.0 / 100

Reference Date: 2026-10-23

Financial Score13.5 / 40
News Sentiment12.5 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Rose 13.6% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Plazmap is a plasma technology company founded in 2015 by KAIST alumni, specializing in bio-plasma applications for the medical device market. Key products include STERLINK (a low-temperature sterilizer using biological inactivation), ACTILINK (a surface activation device for implants using regenerative activation), and CARELINK (a stimulative therapy device for periodontal treatment). The company has achieved global market expansion, including FDA certification in the U.S.

Number of Employees

46people

Average Salary

63.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
3.65Industry Average 1.200.0Point

3.0x industry avg (risky)

ROE
-128.57Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
34.27Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼18.9% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲35.6% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -224.6% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (13%, downtrend)

Current 3,880Won52-week high 8,48052-week low 3,160
1-month return5.0Point

1m +13.62% (rising)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-10-02